Annual Current Liabilities
$57.95 M
+$10.79 M+22.89%
September 30, 2022
Summary
- As of February 10, 2025, VIVO annual total current liabilities is $57.95 million, with the most recent change of +$10.79 million (+22.89%) on September 30, 2022.
- During the last 3 years, VIVO annual current liabilities has risen by +$37.04 million (+177.09%).
Performance
VIVO Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Current Liabilities
$57.95 M
-$2.40 M-3.97%
September 30, 2022
Summary
- As of February 10, 2025, VIVO quarterly total current liabilities is $57.95 million, with the most recent change of -$2.40 million (-3.97%) on September 30, 2022.
- Over the past year, VIVO quarterly current liabilities has increased by +$10.79 million (+22.89%).
Performance
VIVO Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
VIVO Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +22.9% | +22.9% |
| 3 y3 years | +177.1% | +177.1% |
| 5 y5 years | +153.2% | +153.2% |
VIVO Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -18.6% | -4.0% | -13.8% |
| 5 y | 5-year | at high | -63.9% | -4.0% | -39.9% |
| alltime | all time | at high | -99.0% | -4.0% | -99.1% |
Meridian Bioscience Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | $57.95 M(+22.9%) | $57.95 M(-4.0%) |
| Jun 2022 | - | $60.35 M(+6.9%) |
| Mar 2022 | - | $56.47 M(+13.1%) |
| Dec 2021 | - | $49.95 M(+5.9%) |
| Sep 2021 | $47.16 M(-10.2%) | $47.16 M(+28.5%) |
| Jun 2021 | - | $36.70 M(-27.0%) |
| Mar 2021 | - | $50.31 M(-6.5%) |
| Dec 2020 | - | $53.83 M(+2.5%) |
| Sep 2020 | $52.52 M(+151.1%) | $52.52 M(+20.7%) |
| Jun 2020 | - | $43.50 M(+14.8%) |
| Mar 2020 | - | $37.88 M(+8.7%) |
| Dec 2019 | - | $34.85 M(+66.6%) |
| Sep 2019 | $20.91 M(-13.5%) | $20.91 M(+5.5%) |
| Jun 2019 | - | $19.82 M(-17.7%) |
| Mar 2019 | - | $24.08 M(+16.4%) |
| Dec 2018 | - | $20.69 M(-14.4%) |
| Sep 2018 | $24.17 M(+5.6%) | $24.17 M(-1.2%) |
| Jun 2018 | - | $24.46 M(-5.1%) |
| Mar 2018 | - | $25.78 M(+9.8%) |
| Dec 2017 | - | $23.47 M(+2.6%) |
| Sep 2017 | $22.89 M(+1.4%) | $22.89 M(+14.6%) |
| Jun 2017 | - | $19.98 M(+0.4%) |
| Mar 2017 | - | $19.90 M(-5.4%) |
| Dec 2016 | - | $21.04 M(-6.8%) |
| Sep 2016 | $22.57 M(+48.0%) | $22.57 M(+11.5%) |
| Jun 2016 | - | $20.25 M(-4.8%) |
| Mar 2016 | - | $21.27 M(+35.2%) |
| Dec 2015 | - | $15.73 M(+3.2%) |
| Sep 2015 | $15.25 M(+11.0%) | $15.25 M(+14.8%) |
| Jun 2015 | - | $13.29 M(-12.7%) |
| Mar 2015 | - | $15.23 M(+4.7%) |
| Dec 2014 | - | $14.55 M(+5.9%) |
| Sep 2014 | $13.73 M(-30.0%) | $13.73 M(-18.9%) |
| Jun 2014 | - | $16.94 M(-4.9%) |
| Mar 2014 | - | $17.82 M(+1.9%) |
| Dec 2013 | - | $17.49 M(-10.8%) |
| Sep 2013 | $19.62 M(+6.3%) | $19.62 M(-0.5%) |
| Jun 2013 | - | $19.73 M(+11.9%) |
| Mar 2013 | - | $17.63 M(-7.2%) |
| Dec 2012 | - | $19.01 M(+3.0%) |
| Sep 2012 | $18.46 M(+21.0%) | $18.46 M(+5.3%) |
| Jun 2012 | - | $17.54 M(+7.5%) |
| Mar 2012 | - | $16.32 M(-1.4%) |
| Dec 2011 | - | $16.56 M(+8.5%) |
| Sep 2011 | $15.26 M(+5.1%) | $15.26 M(-11.2%) |
| Jun 2011 | - | $17.18 M(+1.3%) |
| Mar 2011 | - | $16.97 M(-3.0%) |
| Dec 2010 | - | $17.48 M(+20.4%) |
| Sep 2010 | $14.52 M(-13.3%) | $14.52 M(+22.0%) |
| Jun 2010 | - | $11.90 M(-6.4%) |
| Mar 2010 | - | $12.72 M(-5.5%) |
| Dec 2009 | - | $13.46 M(-19.6%) |
| Sep 2009 | $16.75 M(+4.3%) | $16.75 M(+37.3%) |
| Jun 2009 | - | $12.20 M(-1.8%) |
| Mar 2009 | - | $12.43 M(-4.7%) |
| Dec 2008 | - | $13.04 M(-18.8%) |
| Sep 2008 | $16.06 M(-5.9%) | $16.06 M(+12.0%) |
| Jun 2008 | - | $14.34 M(-12.6%) |
| Mar 2008 | - | $16.41 M(+5.0%) |
| Dec 2007 | - | $15.62 M(-8.5%) |
| Sep 2007 | $17.07 M(-17.2%) | $17.07 M(+27.4%) |
| Jun 2007 | - | $13.39 M(-10.2%) |
| Mar 2007 | - | $14.92 M(-19.9%) |
| Dec 2006 | - | $18.62 M(-9.7%) |
| Sep 2006 | $20.62 M(+4.2%) | $20.62 M(+23.9%) |
| Jun 2006 | - | $16.64 M(+16.0%) |
| Mar 2006 | - | $14.34 M(-20.2%) |
| Dec 2005 | - | $17.96 M(-9.2%) |
| Sep 2005 | $19.79 M | $19.79 M(-9.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2005 | - | $21.77 M(+2.3%) |
| Mar 2005 | - | $21.29 M(+22.7%) |
| Dec 2004 | - | $17.35 M(+4.2%) |
| Sep 2004 | $16.65 M(+8.6%) | $16.65 M(+3.6%) |
| Jun 2004 | - | $16.08 M(-8.9%) |
| Mar 2004 | - | $17.64 M(+17.8%) |
| Dec 2003 | - | $14.98 M(-2.3%) |
| Sep 2003 | $15.33 M(+0.5%) | $15.33 M(+8.8%) |
| Jun 2003 | - | $14.09 M(+1.3%) |
| Mar 2003 | - | $13.91 M(+7.1%) |
| Dec 2002 | - | $12.99 M(-14.8%) |
| Sep 2002 | $15.25 M(-6.8%) | $15.25 M(+1.8%) |
| Jun 2002 | - | $14.98 M(-3.6%) |
| Mar 2002 | - | $15.54 M(-5.3%) |
| Dec 2001 | - | $16.42 M(+0.3%) |
| Sep 2001 | $16.37 M(-1.6%) | $16.37 M(+9.3%) |
| Jun 2001 | - | $14.98 M(-10.4%) |
| Mar 2001 | - | $16.71 M(-6.1%) |
| Dec 2000 | - | $17.80 M(+7.0%) |
| Sep 2000 | $16.63 M(+22.2%) | $16.63 M(+81.4%) |
| Jun 2000 | - | $9.17 M(-24.3%) |
| Mar 2000 | - | $12.10 M(-3.2%) |
| Dec 1999 | - | $12.50 M(-8.1%) |
| Sep 1999 | $13.60 M(+248.8%) | $13.60 M(+3.8%) |
| Jun 1999 | - | $13.10 M(-4.4%) |
| Mar 1999 | - | $13.70 M(0.0%) |
| Dec 1998 | - | $13.70 M(+251.3%) |
| Sep 1998 | $3.90 M(-9.3%) | $3.90 M(-11.4%) |
| Jun 1998 | - | $4.40 M(-2.2%) |
| Mar 1998 | - | $4.50 M(-10.0%) |
| Dec 1997 | - | $5.00 M(+16.3%) |
| Sep 1997 | $4.30 M(+4.9%) | $4.30 M(+2.4%) |
| Jun 1997 | - | $4.20 M(+2.4%) |
| Mar 1997 | - | $4.10 M(-32.8%) |
| Dec 1996 | - | $6.10 M(+48.8%) |
| Sep 1996 | $4.10 M(+24.2%) | $4.10 M(-63.1%) |
| Jun 1996 | - | $11.10 M(+70.8%) |
| Mar 1996 | - | $6.50 M(+62.5%) |
| Dec 1995 | - | $4.00 M(+21.2%) |
| Sep 1995 | $3.30 M(-25.0%) | $3.30 M(-17.5%) |
| Jun 1995 | - | $4.00 M(+17.6%) |
| Mar 1995 | - | $3.40 M(-2.9%) |
| Dec 1994 | - | $3.50 M(-20.5%) |
| Sep 1994 | $4.40 M(+91.3%) | $4.40 M(0.0%) |
| Jun 1994 | - | $4.40 M(+51.7%) |
| Mar 1994 | - | $2.90 M(+38.1%) |
| Dec 1993 | - | $2.10 M(-8.7%) |
| Sep 1993 | $2.30 M(+21.1%) | $2.30 M(-58.2%) |
| Jun 1993 | - | $5.50 M(+223.5%) |
| Mar 1993 | - | $1.70 M(+21.4%) |
| Dec 1992 | - | $1.40 M(-26.3%) |
| Sep 1992 | $1.90 M(+46.2%) | $1.90 M(0.0%) |
| Jun 1992 | - | $1.90 M(+26.7%) |
| Mar 1992 | - | $1.50 M(+15.4%) |
| Dec 1991 | - | $1.30 M(0.0%) |
| Sep 1991 | $1.30 M(+8.3%) | $1.30 M(+30.0%) |
| Jun 1991 | - | $1.00 M(+25.0%) |
| Mar 1991 | - | $800.00 K(0.0%) |
| Dec 1990 | - | $800.00 K(-33.3%) |
| Sep 1990 | $1.20 M(+71.4%) | $1.20 M(+50.0%) |
| Jun 1990 | - | $800.00 K(0.0%) |
| Mar 1990 | - | $800.00 K(+14.3%) |
| Dec 1989 | - | $700.00 K(0.0%) |
| Sep 1989 | $700.00 K(+16.7%) | $700.00 K(+40.0%) |
| Jun 1989 | - | $500.00 K(-16.7%) |
| Sep 1988 | $600.00 K(-33.3%) | $600.00 K(-33.3%) |
| Sep 1987 | $900.00 K(-10.0%) | $900.00 K(-10.0%) |
| Sep 1986 | $1.00 M(0.0%) | $1.00 M(0.0%) |
| Sep 1985 | $1.00 M | $1.00 M |
FAQ
- What is Meridian Bioscience annual total current liabilities?
- What is the all time high annual current liabilities for Meridian Bioscience?
- What is Meridian Bioscience annual current liabilities year-on-year change?
- What is Meridian Bioscience quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Meridian Bioscience?
- What is Meridian Bioscience quarterly current liabilities year-on-year change?
What is Meridian Bioscience annual total current liabilities?
The current annual current liabilities of VIVO is $57.95 M
What is the all time high annual current liabilities for Meridian Bioscience?
Meridian Bioscience all-time high annual total current liabilities is $57.95 M
What is Meridian Bioscience annual current liabilities year-on-year change?
Over the past year, VIVO annual total current liabilities has changed by +$10.79 M (+22.89%)
What is Meridian Bioscience quarterly total current liabilities?
The current quarterly current liabilities of VIVO is $57.95 M
What is the all time high quarterly current liabilities for Meridian Bioscience?
Meridian Bioscience all-time high quarterly total current liabilities is $60.35 M
What is Meridian Bioscience quarterly current liabilities year-on-year change?
Over the past year, VIVO quarterly total current liabilities has changed by +$10.79 M (+22.89%)